| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.2 | 9e-08 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.27 | 1e-05 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |